Table 1 Characteristics of the patients with Ataxia-telangiectasia
Variables | Â | N (%) |
|---|---|---|
Age (n = 25) | Children (< 10 years) | 9 (36.0%) |
Adolescents (10 to 19Â years) | 11 (44.0%) | |
Adults (≥ 20 years) | 5 (20.0%) | |
Nutritional status (n = 25) | Underweight | 8 (32.0%) |
Adequate | 16 (64.0%) | |
Overweight | 1 (4.0%) | |
Fat mass (n = 24) | Low | 4 (16.7%) |
Adequate | 13 (54.1%) | |
High | 7 (29.1%) | |
MUAMC (n = 24) | Low | 13 (54.1%) |
Adequate | 11 (45.8%) | |
WHtR (n = 24) | Adequate | 20 (83.3%) |
High | 4 (16.7%) | |
Pubertal stage (n = 25) | Prepubertal | 9 (36.0%) |
Pubertal | 8 (32.0%) | |
Postpubertal | 8 (32.0%) | |
ICARS (n = 25) | Mild ataxia | 3 (12.0%) |
Moderate ataxia | 13 (52.0%) | |
Severe ataxia | 9 (36.0%) | |
hs-CRP (n = 25) |  > 1 mg/L | 7 (28.0%) |
 ≤ 1 mg/L | 18 (72.0%) | |
Lipid profile (n = 25) | High total cholesterol | 5 (20.0%) |
High LDL-c | 5 (20.0%) | |
High triglycerides | 6 (24.0%) | |
Low HDL-c | 8 (32.0%) | |
High NHDL-c | 14 (56.0%) | |
Glucose metabolism (n = 23) | Diabetes | 4 (17.4%) |
Insulin resistance** (n = 21) | 5 (23.8%) | |
Hepatic steatosis (n = 20) | Absent | 7 (35.0%) |
Mild | 8 (40.0%) | |
Moderate | 5 (25.0%) | |
Significant liver fibrosis (n = 25) |  | 5 (20.0%) |
ALT (U/L) (n = 25) |  ≥ 2 xULN | 4 (16.0%) |
AST (U/L) (n = 25) |  ≥ 2 xULN | 2 (8.0%) |